Molecular and cellular responses to DNA damage in a murine pituitary adenoma cell line

Molecular and Cellular Endocrinology

Volumn 119, Issue 1, 1996, Pages 61-68

  Woloschak, M ^a   Yu, A ^a   Xiao, J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; bcl 2; c myc; p53; Pituitary

Indexed keywords

DNA FRAGMENT; ETHIDIUM BROMIDE; PROPIDIUM IODIDE; PROTEIN P53; TRYPAN BLUE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL VACUOLE; CHROMATIN CONDENSATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; FLOW CYTOMETRY; HYPOPHYSIS; HYPOPHYSIS ADENOMA; IMMUNOBLOTTING; IRRADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029952593     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/0303-7207(96)03795-1     Document Type: Article

References (42)

1. Alexander, J.M., Biller, B.M.K., Bikkal, H., Zervas, N.T., Arnold, A. and Klibanski, A. (1990) Clinically nonfunctioning pituitary tumors are monoclonal in origin. J. Clin. Invest. 86, 336-340.
2. Herman, V., Fagin, J., Gonsky, R., Kovacs, K. and Melmed, S. (1990) Clonal origins of pituitary adenomas. J. Clin. Endocrinol. Metab. 71, 1427-1433.
3. Vallar, L., Spada, A. and Giannattasio, G. (1987) Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature 330, 566-8.
4. Landis, C.A., Masters, S.B., Spada, A., Pace, A.M., Bourne, H.R. and Vallar, L. (1989) GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylate cyclase in human pituitary tumors. Nature 340, 692-696.
5. Karga, H.J., Alexander, J.M., Hedley-Whyte, E.T., Klibanski, A. and Jameson, J.L. (1992) Ras mutations in human pituitary tumors. J. Clin. Endocrinol. Metab. 74, 914-919.
6. Herman, V., Drazin, N.Z., Gonsky, R. and Melmed, S. (1993) Molecular screening of pituitary adenomas for gene mutations and rearrangements. J. Clin. Endocrinol. Metab. 77, 50-55.
7. Lee, E.Y.-H.P., Chang, C-Y., Hu, N., Wang, Y.-C.J., Lai, C.-C., Herrup, K. et al. (1992) Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359, 288-295.
8. Jacks, T., Fazeli, A., Schmitt, E.M., Bronson, R.T., Goodell, M.A. and Weinberg, R.A. (1992) Effects of an Rb mutation in the mouse. Nature 359, 295-300.
9. Woloschak, M., Roberts, J.L. and Post, K.D. (1994) Loss of heterozygosity at the retinoblastoma locus in human pituitary tumors. Cancer 74, 693-696.
10. Cryns, V.L., Alexander, J.M., Klibanski, A. and Arnold, A. (1993) The retinoblastoma gene in human pituitary tumors. J. Clin. Endocrinol. Metab. 77, 644-646.
11. Woloschak, M., Yu, A. and Post, K. (1995) Detection of polyomaviral DNA sequences in normal and adenomatous human pituitary tissues using the polymerase chain reaction. Cancer 76, 490-496.
12. Maity, A., McKenna, W.G. and Muschel, R.J. (1994) The molecular basis for cell cycle delays following ionizing radiation: a review. Radiother. Oncol. 31, 1-13.
13. Williams, G.T., Smith, C.A., McCarthy, N.J. and Grimes, E.A. (1992) Apoptosis: final control point in cell biology. Trends Cell Biol. 2, 263-267.
14. Kuerbitz, S.J., Plunkelt, B.S., Walsh, W.V. and Kastan, M.B. (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Nat. Acad. Sci. USA 89, 7491-7495.
15. O'Connor, P.M., Jackman, J., Jondle, D., Bhatia, K., Magrath, I. and Kohn, K.W. (1993) Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res. 53, 4776-4780.
16. Wyllie, A.H., Kerr, J.F.R. and Currie, A.R. (1980) Cell death: the significance of apoptosis. Int. Rev. Cytol. 68, 251-306.
17. Korsmeyer, S.J. (1992) Bcl-2: an antidote to programmed cell death. Cancer Surv. 15, 105-118.
18. Vaux, D.L. (1993) Toward an understanding of the molecular mechanisms of physiological cell death. Proc. Nat. Acad. Sci. USA 90, 786-789.
19. Clarke, A.R., Purdie, C.A., Harrison, D.J., Morris, R.G., Bird, C.C., Hooper, M.L. and Wyllie, A.H. (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362, 849-852.
20. Askew, D.S., Ashmun, R.A., Simmons, B.C. and Cleveland, J.L. (1991) Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6, 1915-1922.
21. Negrini, M., Silini, E., Kozak, C., Tsujimoto, Y. and Croce, C.M. (1987) Molecular analysis of mbcl-2: structure and expression of the murine gene homologous to the human gene involved in follicular lymphoma. Cell 49, 455-463.
22. Nicoletti, I., Migliorati, G., Pagliacci, M.C., Grignani, F. and Riccardi, C. (1991) A rapid and simple method for measuring thymocytes apoptosis by propidium iodide staining and flow cytomctry. J. Immunol. Methods 139, 271-279.
23. Yin, D., Kondo, S., Takeuchi, J. and Morimura, T. (1994) Induction of apoptosis in murine ACTH-secreting pituitary adenoma cells by bromocriptine. FEBS Lett. 339, 73-75.
24. Boe, R., Gjertsen, B.T., Vintermyr, O.K., Houge, G., Lanotte, O.M. and Doskeland, S.O. (1991) The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells. Exp. Cell Res. 195, 237-246.
25. Cohen, G.M., Sun, X.M., Snowden, R.T., Dinsdale, D. and Skilleter, D.N. (1992) Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem. J. 286, 331-334.
26. Collins, R.J., Harmon, B.V., Gobe, G.C. and Kerr, J.F.R. (1992) Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int. J. Radiat. Biol. 61. 451-453.
27. Vogelstein, B. and Kinzler, K.W. (1992) p53 function and dysfunction. Cell 70, 523-526.
28. Levine, A., Momand, J. and Finlay, C.A. (1991) The p53 tumor suppressor gene. Nature 351, 453-456.
29. Kramer, S. (1973) Indications for. and results of. treatment of pituitary tumors by external radiation. In: Diagnosis and Treatment of Pituitary Tumors (Kohler, P.O., ed.), Elsevier. New York.
30. Thulasi, R., Harbour, D.V. and Thompson, E.B. (1993) Suppression of c-myc is a critical step in glucocorticoid-induced human leukemic cell lysis. J. Biol. Chem. 268, 18306-18312.
31. Marcu, K.B., Bossone, S.A. and Patel, A.J. (1992) Myc function and regulation. Ann. Rev. Biochem. 61, 809-860.
32. Wang, E. and Pandey, S. (1995) Down-regulation of statin, a nonproliferation-specific nuclear protein, and tip-regulation of c-myc after initiation of programmed cell death in mouse fibroblasts. J. Cell. Physiol. 163, 155-163.
33. Helmberg, A., Auphan, N., Caelics, C. and Karin, M. (1995) Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J. 14, 452-460.
34. Wood, A.C., Elvin, P. and Hickman, J.A. (1995) Induction of apoptosis by anti-cancer drugs with disparate modes of action: kinetics of cell death and changes in c-myc expression. Br. J. Cancer 71, 937-941.
35. Woloschak, M., Roberts, J.L. and Post, K.D. (1994) C-myc, c-fos, and c-myb gene expression in human pituitary adenomas. J. Clin. Endocrinol. Metab, 79, 253-257.
36. Cutrona, G., Ulivi, M., Fais, F., Roncella, S. and Ferrarini, M. (1995) Transfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt's lymphoma cells and normal centroblasts. J. Exp. Med. 181, 699-711.
37. Delia, D., Aiello, A., Formelli, F., Fontanella, E., Costa, A., Miyashita, T., Reed, J.C. and Pierotti, M.A. (1995) Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl)retinamide and effect of deregulated bcl-2. Blood 85, 359-367.
38. Choi, M.S., Boise, L.H., Gottschalk, A.R., Quintans, J., Thompson, C.B. and Klauss, G.G. (1995) The role of bcl-XL in CD40-mediated rescue from anti-mu-induced apoptosis in WEHI-231 B lymphoma cells. Eur. J. Immunol. 25, 1352-1357.
39. Lomo, J., Blomhoff, H.K., Beiske, K., Stokke, T. and Smeland, E.B. (1995) TGF-beta 1 and cyclic AMP promote apoptosis in resting B lymphocytes. J. Immunol. 154, 1634-1643.
40. Drewett, N., Jacobi, J.N., Willgoss, D.A. and Lloyd, H.M. (1993) Apoptosis in the anterior pituitary gland of the rat: studies with estrogen and bromocriptine. Neuroendocrinology 57, 89-95.
41. Leek, R.D., Kaklamanis, L., Pezzella, F., Gatter, K.C. and Harris, A.L. (1994) Bcl-2 in normal human breast and carcinoma, association with estrogen receptor-positive, epidermal growth factor-negative tumors and in situ cancer. Br. J. Cancer 69, 135-139.
42. Bhargava, V., Kell, D.L., van de Rijn, M. and Warnke, R.A. (1994) Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. Am. J. Pathol. 145, 535-540.